To evaluate the incidence and predictors of early postoperative acute kidney injury (EP-AKI) during index hospitalization following radical cystectomy and its association with postoperative outcomes.
All patients with bladder cancer who underwent radical cystectomy with intent-to-cure at our center between 2012 and 2020 were reviewed. EP-AKI during index hospitalization was evaluated using the Acute Kidney Injury Network criteria. The association between EP-AKI and demographics, clinicopathologic features, and perioperative outcomes, including length of hospital stay, complication rate, and readmission rate, were examined. A logistic regression analysis was performed to evaluate the predictors of EP-AKI.
Overall, 435 patients met eligibility, of whom 112 (26%) experienced EP-AKI during index hospitalization (90 [21%] stage 1, 17 [4%] stage 2, and 5 [1%] stage 3). EP-AKI was associated with a longer mean operative time (6.8 vs. 6.1 hours; P < 0.001), higher mean length of hospital stay (6.3 vs. 5.6; P = 0.02), 30-day complication rate (71% vs. 51%; P < 0.001), 90-day complication rate (81% vs. 69%; P = 0.01) and 90-day readmission rate (37% vs. 33%; P = 0.04). The rate of complications increased at higher stages of AKI. On multivariable analysis, perioperative blood transfusion (OR: 1.84, P = 0.02) and continent diversion (OR: 3.29, P < 0.001) were independent predictors of EP-AKI.
A quarter of cystectomy patients experience acute kidney injury during index hospitalization, which is associated with higher length of stay, postoperative complication, and readmission rates. Perioperative blood transfusion and continent diversion are independent predictors of such injury.
Urologic oncology. 2023 Mar 24 [Epub ahead of print]
Sina Sobhani, Muhannad Alsyouf, Hamed Ahmadi, Alireza Ghoreifi, Wenhao Yu, Giovanni Cacciamani, Gus Miranda, Jie Cai, Sumeet Bhanvadia, Anne Schuckman, Monish Aron, Inderbir Gill, Siamak Daneshmand, Mihir Desai, Hooman Djaladat
Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA., Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Department of Urology, University of Minnesota, Minneapolis, MN., Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA. Electronic address: .
PubMed http://www.ncbi.nlm.nih.gov/pubmed/36967251